| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
|
Ann Neurol
|
2004
|
21.56
|
|
2
|
Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
|
J Cereb Blood Flow Metab
|
2007
|
11.79
|
|
3
|
Frequent amyloid deposition without significant cognitive impairment among the elderly.
|
Arch Neurol
|
2008
|
7.95
|
|
4
|
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
|
Brain
|
2008
|
5.89
|
|
5
|
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.
|
Proc Natl Acad Sci U S A
|
2009
|
5.55
|
|
6
|
Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.
|
J Nucl Med
|
2005
|
5.10
|
|
7
|
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.
|
Ann Neurol
|
2007
|
4.11
|
|
8
|
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.
|
J Neurosci
|
2007
|
3.91
|
|
9
|
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.
|
Alzheimers Dement
|
2010
|
3.30
|
|
10
|
Functional neuroimaging evidence for hyperarousal in insomnia.
|
Am J Psychiatry
|
2004
|
2.87
|
|
11
|
Amyloid imaging in mild cognitive impairment subtypes.
|
Ann Neurol
|
2009
|
2.66
|
|
12
|
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
|
J Neurosci
|
2005
|
2.17
|
|
13
|
Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.
|
J Neurosci
|
2009
|
1.89
|
|
14
|
Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study.
|
Fertil Steril
|
2007
|
1.82
|
|
15
|
Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride.
|
Biol Psychiatry
|
2005
|
1.80
|
|
16
|
Regional cerebral metabolic correlates of WASO during NREM sleep in insomnia.
|
J Clin Sleep Med
|
2006
|
1.76
|
|
17
|
Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.
|
Neuroimage
|
2006
|
1.65
|
|
18
|
Serotonin transporter binding after recovery from eating disorders.
|
Psychopharmacology (Berl)
|
2007
|
1.57
|
|
19
|
Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking.
|
Brain
|
2002
|
1.50
|
|
20
|
Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.
|
J Neurosci Methods
|
2008
|
1.46
|
|
21
|
Serotonin 1A receptor binding and treatment response in late-life depression.
|
Neuropsychopharmacology
|
2004
|
1.35
|
|
22
|
Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B.
|
Alzheimer Dis Assoc Disord
|
2008
|
1.30
|
|
23
|
Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements.
|
J Nucl Med
|
2009
|
1.27
|
|
24
|
Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling.
|
Cereb Cortex
|
2009
|
1.26
|
|
25
|
Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies.
|
Arch Neurol
|
2005
|
1.18
|
|
26
|
Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.
|
Neuroimage
|
2013
|
1.17
|
|
27
|
In vivo assessment of amyloid-β deposition in nondemented very elderly subjects.
|
Ann Neurol
|
2013
|
1.17
|
|
28
|
Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa.
|
Biol Psychiatry
|
2007
|
1.17
|
|
29
|
Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.
|
Acta Neuropathol
|
2012
|
1.16
|
|
30
|
Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
|
Arch Gen Psychiatry
|
2005
|
1.16
|
|
31
|
Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET.
|
Neuroimage
|
2010
|
1.13
|
|
32
|
Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia.
|
Neurology
|
2013
|
1.11
|
|
33
|
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
|
Brain
|
2006
|
1.07
|
|
34
|
Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography.
|
Neuroimaging Clin N Am
|
2003
|
1.07
|
|
35
|
Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B.
|
Alzheimers Dement
|
2012
|
1.03
|
|
36
|
Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects.
|
Neuropsychopharmacology
|
2008
|
1.03
|
|
37
|
Alterations in regional cerebral glucose metabolism across waking and non-rapid eye movement sleep in depression.
|
Arch Gen Psychiatry
|
2005
|
1.03
|
|
38
|
Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.
|
Psychiatry Res
|
2012
|
1.02
|
|
39
|
Interactions between delivery, transport, and phosphorylation of glucose in governing uptake into human skeletal muscle.
|
Diabetes
|
2006
|
0.99
|
|
40
|
Amyloid imaging in dementias with atypical presentation.
|
Alzheimers Dement
|
2012
|
0.99
|
|
41
|
Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
|
Neuropsychopharmacology
|
2004
|
0.98
|
|
42
|
Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studies.
|
Synapse
|
2009
|
0.97
|
|
43
|
Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model.
|
J Clin Endocrinol Metab
|
2003
|
0.96
|
|
44
|
5HT2A receptor binding is increased in borderline personality disorder.
|
Biol Psychiatry
|
2007
|
0.96
|
|
45
|
Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635.
|
Synapse
|
2007
|
0.95
|
|
46
|
Reduced 5-HT2A receptor binding after recovery from anorexia nervosa.
|
Biol Psychiatry
|
2002
|
0.95
|
|
47
|
MR atlas of the baboon brain for functional neuroimaging.
|
Brain Res Bull
|
2002
|
0.94
|
|
48
|
Increased activation of anterior paralimbic and executive cortex from waking to rapid eye movement sleep in depression.
|
Arch Gen Psychiatry
|
2004
|
0.94
|
|
49
|
In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers.
|
Am J Psychiatry
|
2011
|
0.93
|
|
50
|
Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies.
|
Physiol Behav
|
2005
|
0.90
|
|
51
|
Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population.
|
Neuropsychopharmacology
|
2011
|
0.89
|
|
52
|
Identification of hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease.
|
J Cereb Blood Flow Metab
|
2004
|
0.88
|
|
53
|
Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities.
|
Neuropsychologia
|
2013
|
0.88
|
|
54
|
5-HT₁A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups.
|
Int J Eat Disord
|
2010
|
0.87
|
|
55
|
Postpartum and depression status are associated with lower [[¹¹C]raclopride BP(ND) in reproductive-age women.
|
Neuropsychopharmacology
|
2012
|
0.86
|
|
56
|
Lack of association between prior depressive episodes and cerebral [11C]PiB binding.
|
Neurobiol Aging
|
2011
|
0.86
|
|
57
|
Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study.
|
Synapse
|
2011
|
0.86
|
|
58
|
Medial prefrontal cortex serotonin 1A and 2A receptor binding interacts to predict threat-related amygdala reactivity.
|
Biol Mood Anxiety Disord
|
2011
|
0.85
|
|
59
|
Gender, personality, and serotonin-2A receptor binding in healthy subjects.
|
Psychiatry Res
|
2010
|
0.84
|
|
60
|
Assessment of parameter settings for SPM5 spatial normalization of structural MRI data: application to type 2 diabetes.
|
Neuroimage
|
2008
|
0.84
|
|
61
|
Association of small vessel ischemic white matter changes with BOLD fMRI imaging in the elderly.
|
Psychiatry Res
|
2012
|
0.83
|
|
62
|
Regional cerebral blood flow after recovery from anorexia or bulimia nervosa.
|
Int J Eat Disord
|
2007
|
0.82
|
|
63
|
Quantitative imaging of protein targets in the human brain with PET.
|
Phys Med Biol
|
2015
|
0.82
|
|
64
|
Positron emission tomography imaging of the aging brain.
|
Neuroimaging Clin N Am
|
2003
|
0.81
|
|
65
|
Brain function, cognition, and the blood pressure response to pharmacological treatment.
|
Psychosom Med
|
2010
|
0.79
|
|
66
|
Altered cerebellar and prefrontal cortex function in rhesus monkeys that previously self-administered cocaine.
|
Psychopharmacology (Berl)
|
2014
|
0.78
|
|
67
|
Interactions among glucose delivery, transport, and phosphorylation that underlie skeletal muscle insulin resistance in obesity and type 2 Diabetes: studies with dynamic PET imaging.
|
Diabetes
|
2013
|
0.78
|
|
68
|
Dynamic PET imaging reveals heterogeneity of skeletal muscle insulin resistance.
|
J Clin Endocrinol Metab
|
2013
|
0.77
|
|
69
|
Comparing neural correlates of REM sleep in posttraumatic stress disorder and depression: a neuroimaging study.
|
Psychiatry Res
|
2013
|
0.77
|
|
70
|
Components of a curriculum for molecular imaging scientists.
|
J Nucl Med
|
2011
|
0.75
|